1.67 USD
▼-0.05-2.91%
盘后 1.64 -1.72%
2026-11-19
市值
$681.21M
市盈率
—
EPS
-0.15
股息率
—
52 周区间
1.10 – 2.68
成交量
1.55M
Beta
1.08
目标价
4.52
52W 低 1.1052W 高 2.68
价格走势
公司简介
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart fail...